JOSIE SENGER: Open Payments
NPI 1356820922 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 20 payments from 10 companies in 2025. Trend: 2023 $284 · 2024 $544 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $105 |
| Astellas Pharma US Inc | 2 | $48 |
| ABBVIE INC. | 2 | $44 |
| PFIZER INC. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, Veozah, TRINTELLIX, MOUNJARO, UBRELVY, QULIPTA, ELIQUIS, Auvelity.
Industry payments across ND — which companies pay providers there.
